Allogene Therapeutics (ALLO) Amortizatization of Intangibles (2018 - 2026)
Allogene Therapeutics recorded quarterly Amortizatization of Intangibles of $885000.0 in Q1 2026, up 7.8% quarter-over-quarter from $821000.0 in Q4 2025, and down 32.24% year-over-year from $1.3 million in Q1 2025.
Allogene Therapeutics' Amortizatization of Intangibles history runs 9 years deep, the most recent figure standing at $885000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 32.24% year-over-year to $885000.0; the TTM figure through Mar 2026 stood at $3.8 million (down 44.58% YoY), while the FY2025 annual figure was $4.2 million, down 49.44% from the prior year.
- Amortizatization of Intangibles came in at $885000.0 for Q1 2026 at Allogene Therapeutics, up from $821000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $3.3 million in Q4 2023 to a low of -$1.3 million in Q1 2022.
- A 5-year average of $1.0 million and a median of $1.1 million in 2023 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles soared 2214.74% in 2023 and plunged 53.31% in 2025, its largest moves.
- Allogene Therapeutics' Amortizatization of Intangibles stood at -$156000.0 in 2022, then jumped by 2214.74% to $3.3 million in 2023, then plunged by 49.95% to $1.7 million in 2024, then plunged by 50.27% to $821000.0 in 2025, then grew by 7.8% to $885000.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $885000.0, $821000.0, and $923000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Allogene Therapeutics | 521.43 Mn | 521.43 Mn | - | 885,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 885,000.00 |
| Mar 31, 2026 | 885,000.00 |
| Dec 31, 2025 | 821,000.00 |
| Dec 31, 2025 | 821,000.00 |
| Sep 30, 2025 | 923,000.00 |
| Sep 30, 2025 | 923,000.00 |
| Jun 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 1.31 Mn |
| Mar 31, 2025 | 1.31 Mn |
| Dec 31, 2024 | 1.65 Mn |
| Dec 31, 2024 | 1.65 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Mar 31, 2024 | 2.80 Mn |
| Mar 31, 2024 | 2.80 Mn |
| Dec 31, 2023 | 3.30 Mn |
| Dec 31, 2023 | 3.30 Mn |
| Sep 30, 2023 | 2.94 Mn |
| Sep 30, 2023 | 2.94 Mn |
| Jun 30, 2023 | 1.07 Mn |
| Jun 30, 2023 | 1.07 Mn |
| Mar 31, 2023 | -508,000.00 |
| Mar 31, 2023 | -508,000.00 |
| Dec 31, 2022 | -156,000.00 |
| Dec 31, 2022 | -156,000.00 |
| Sep 30, 2022 | -495,000.00 |
| Sep 30, 2022 | -495,000.00 |
| Jun 30, 2022 | -908,000.00 |
| Jun 30, 2022 | -908,000.00 |
| Mar 31, 2022 | -1.33 Mn |
| Mar 31, 2022 | -1.33 Mn |
| Dec 31, 2021 | -1.59 Mn |
| Dec 31, 2021 | -1.59 Mn |
| Sep 30, 2021 | -1.62 Mn |
| Sep 30, 2021 | -1.62 Mn |
| Jun 30, 2021 | -1.84 Mn |
| Jun 30, 2021 | -1.84 Mn |
| Mar 31, 2021 | -1.91 Mn |
| Mar 31, 2021 | -1.91 Mn |
| Dec 31, 2020 | 1.59 Mn |
| Dec 31, 2020 | 1.59 Mn |
| Sep 30, 2020 | -1.59 Mn |
| Sep 30, 2020 | -1.59 Mn |
| Jun 30, 2020 | -56,000.00 |
| Jun 30, 2020 | -56,000.00 |
| Mar 31, 2020 | 207,000.00 |
| Mar 31, 2020 | 207,000.00 |
| Dec 31, 2019 | 151,000.00 |
| Dec 31, 2019 | 151,000.00 |
| Sep 30, 2019 | 151,000.00 |
| Sep 30, 2019 | 151,000.00 |
| Jun 30, 2019 | -922,000.00 |
| Jun 30, 2019 | -922,000.00 |
| Mar 31, 2019 | 1.22 Mn |
| Mar 31, 2019 | 1.22 Mn |
| Dec 31, 2018 | 150,000.00 |
| Dec 31, 2018 | 150,000.00 |
| Sep 30, 2018 | 200,000.00 |
| Sep 30, 2018 | 200,000.00 |